Pharmacovigilance

Pharmacovigilance is the set of activities aimed at the detection, evaluation and understanding of the adverse events that may occur during the use of medicines after they have been granted a marketing authorization by our health authority ANMAT (National Administration of Medicines, Food, and Medical Technology), in order to establish new safety and prevention information. The main goal of Pharmacovigilance is to help enhance safe and rational use of medicines. Among its activities are:

An adverse event is an undesired incident that may occur after the administration of a drug regardless of the relationship to it. Your report helps to detect and minimize possible risks associated with the use of medications.

Any adverse event experienced by the patient during a drug treatment.
Inquiries related to health conditions, medicine prescriptions or medical consultations should be channeled through the treating physician.
For further information related to adverse events, please visit http://www.anmat.gov.ar/farmacovigilancia/Glosario_FVG.pdf

Any patient or healthcare professional that has knowledge of any of the situations previously described with at least one of our products.

You can contact us through the following means:
By phone: (+ 54 11) 4122 5818 from Monday to Friday from 8 am to 5 pm
By e-mail: farmacovigilancia@baliarda.com.ar
By completing the following form: ENTER THE FORM

The information provided through these communication channels will be confidential.

Risk management plans (RMPs) are defined as a group of Pharmacovigilance activities and interventions designed to identify, characterize in an early way and prevent or minimize the risks associated to the use of medicines.
Risk management plans are generally required for new products, in which case it is necessary to perform additional follow-ups during the first years of commercialization, or for products that are known to bear specific safety issues that imply monitoring.
To verify if a product from Baliarda has a RMP, please check the product information provided in the section“PRODUCTS”.